Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 global studies. Researchers found that although these medications, including GLP-1-based treatments like semaglutide and tirzepatide,

Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount of weight, the company said.

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight loss like Ozempic. Here's the deal.